RxDoctor Payments Data

Giles Robinson

Pediatric Hematology-Oncology · Memphis, TNNPI 1922027200

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,200 of the $6,729 with a category attached, or 77.3%. F. Hoffmann-la Roche AG accounts for 62.1% of it on its own, with 2 other manufacturers making up the rest.

$6,729in general payments, 2019–2025

Across 11 payments — averaging $611.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • F. Hoffmann-la Roche AG$4K
  • Hoffmann-la Roche Limited$1K
  • Genentech, Inc.$1K
$2,602,132in research payments, 2019–2025

Across 34 payments — averaging $76,533 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$2.6M
  • F. Hoffmann-la Roche AG$9K
  • Pfizer$2K

What the payments were for

  • Consulting fees$5,20077%
  • Speaking & faculty fees$1,31420%
  • Food & beverage$2163%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,729 in reported general payments places this provider in the 65th percentile of 113 pediatric hematology-oncology providers in Tennessee.

See all pediatric hematology-oncology providers in Tennessee

Other pediatric hematology-oncology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →